Obesity Impact on Outcomes of Myelodysplastic Syndromes

被引:0
|
作者
Al Ali, Najla [1 ]
Sallman, David [1 ]
Padron, Eric [1 ]
Lancet, Jeffery [1 ]
List, Alan [1 ]
Komrokji, Rami [1 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源
关键词
Myelodysplastic Syndromes; Body Mass Index; Overall survival;
D O I
10.1016/j.clml.2018.07.174
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MDS-256
引用
收藏
页码:S262 / S262
页数:1
相关论文
共 50 条
  • [1] Impact of obesity on survival of patients with myelodysplastic syndromes
    Schwabkey, Zaker
    Al Ali, Najla
    Sallman, David
    Kuykendall, Andrew
    Talati, Chetasi
    Sweet, Kendra
    Lancet, Jeffrey
    Padron, Eric
    Komrokji, Rami
    HEMATOLOGY, 2021, 26 (01) : 393 - 397
  • [2] The Impact of Oral Hypoglycemics and Statins on Outcomes in Myelodysplastic Syndromes
    Brailovski, Eugene
    Li, Qing
    Liu, Ning
    Leber, Brian
    Khalaf, Dina
    Sabloff, Mitchell
    Christou, Grace
    Yee, Karen
    Chodirker, Lisa
    Parmentier, Anne
    Siddiqui, Mohammed
    Mamedov, Alexandre
    Zhang, Liying
    Liu, Ying
    Earle, Craig C.
    Cheung, Matthew
    Mittman, Nicole
    Buckstein, Rena J.
    Mozessohn, Lee
    BLOOD, 2021, 138
  • [3] The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes
    Eugene Brailovski
    Qing Li
    Ning Liu
    Brian Leber
    Dina Khalaf
    Mitchell Sabloff
    Grace Christou
    Karen Yee
    Lisa Chodirker
    Anne Parmentier
    Mohammed Siddiqui
    Alexandre Mamedov
    Liying Zhang
    Ying Liu
    Craig C. Earle
    Matthew C. Cheung
    Nicole Mittmann
    Rena J. Buckstein
    Lee Mozessohn
    Annals of Hematology, 2022, 101 : 1023 - 1030
  • [4] The impact of oral hypoglycemics and statins on outcomes in myelodysplastic syndromes
    Brailovski, Eugene
    Li, Qing
    Liu, Ning
    Leber, Brian
    Khalaf, Dina
    Sabloff, Mitchell
    Christou, Grace
    Yee, Karen
    Chodirker, Lisa
    Parmentier, Anne
    Siddiqui, Mohammed
    Mamedov, Alexandre
    Zhang, Liying
    Liu, Ying
    Earle, Craig C.
    Cheung, Matthew C.
    Mittmann, Nicole
    Buckstein, Rena J.
    Mozessohn, Lee
    ANNALS OF HEMATOLOGY, 2022, 101 (05) : 1023 - 1030
  • [5] Impact of preexisting autoimmune disease on myelodysplastic syndromes outcomes: a population analysis
    Adrianzen-Herrera, Diego
    Sparks, Andrew D.
    Singh, Rohit
    Alejos-Castillo, David
    Batra, Akshee
    Glushakow-Smith, Shira
    Pradhan, Kith
    Shastri, Aditi
    Zakai, Neil A.
    BLOOD ADVANCES, 2023, 7 (22) : 6913 - 6922
  • [6] Transfusion independence in patients with myelodysplastic syndromes - Impact on outcomes and quality of life
    Balducci, L
    CANCER, 2006, 106 (10) : 2087 - 2094
  • [7] The Impact of Comorbidity in Myelodysplastic Syndromes
    Huang, Yu-Chung
    Chen, Kuo-Wei
    Hong, Ying-Chung
    Liu, Chia-Jen
    Yu, Yuan-Bin
    Tzeng, Cheng-Hwai
    BLOOD, 2012, 120 (21)
  • [8] Obesity and genomic changes in patients with myelodysplastic syndromes
    Nazha, Aziz
    Seastone, David
    Makishima, Hideki
    Kalaycio, Matt
    Carraway, Hetty E.
    Advani, Anjali S.
    Zarzour, Ahamd
    Carew, Jennifer
    Gerds, Aaron T.
    Mukherjee, Sudipto
    Maciejewski, Jaroslaw P.
    Sekeres, Mikkael A.
    CANCER RESEARCH, 2015, 75
  • [9] On the basis of sex: outcomes in myelodysplastic syndromes
    Gagelmann, Nico
    Brudno, Jennifer
    LANCET HAEMATOLOGY, 2023, 10 (02): : E83 - E83
  • [10] Impact of socioeconomic status on disease phenotype, genomic landscape and outcomes in myelodysplastic syndromes
    Mastaglio, Francesca
    Bedair, Khaled
    Papaemmanuil, Elli
    Groves, Michael J.
    Hyslop, Ann
    Keenan, Norene
    Hothersall, Eleanor J.
    Campbell, Peter J.
    Bowen, David T.
    Tauro, Sudhir
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (02) : 227 - 234